Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Clinical Data
Special Reports
2021's top 10 clinical trial flops
Thousands of studies are registered each year, so there is always an array of disappointing results to choose from for our annual top 10 list.
Phil Taylor
Mar 1, 2022 3:00am
ASCO: Zentalis ovarian cancer data will take WEE1 to phase 3
May 26, 2023 8:40am
ASCO: Roche's TIGIT finally shows signs of life in liver cancer
May 26, 2023 7:13am
ASCO: Regeneron's Opdualag rival records 61% response rate
May 25, 2023 6:00pm
Annexon eye disease med failed phase 2 goal—the CEO is thrilled
May 24, 2023 4:01pm
Mirati's wait for next lung cancer med ends in phase 3 failure
May 24, 2023 4:00pm
More News
PTC plots path to rare disease approval despite phase 3 fail
May 24, 2023 6:20am
Wave's ALS-dementia drug crashes out after early-phase flop
May 23, 2023 9:30am
Achieve's anti-smoking drug beats placebo in 2nd phase 3
May 23, 2023 9:00am
BMS' pulmonary fibrosis drug reduces lung function decline
May 22, 2023 1:05pm
See more stories